Histone deacetylase 7: a signalling hub controlling development, inflammation, metabolism and disease.

Abstract

Histone deacetylases (HDACs) catalyse removal of acetyl groups from lysine residues on both histone and non-histone proteins to control numerous cellular processes. Of the 11 zinc-dependent classical HDACs, HDAC4, 5, 7 and 9 are class IIa HDAC enzymes that regulate cellular and developmental processes through both enzymatic and non-enzymatic mechanisms. Over the last two decades, HDAC7 has been associated with key roles in numerous physiological and pathological processes. Molecular, cellular, in vivo and disease association studies have revealed that HDAC7 acts through multiple mechanisms to control biological processes in immune cells, osteoclasts, muscle, the endothelium and epithelium. This HDAC protein regulates gene expression, cell proliferation, cell differentiation and cell survival and consequently controls development, angiogenesis, immune functions, inflammation and metabolism. This review focuses on the cell biology of HDAC7, including the regulation of its cellular localisation and molecular mechanisms of action, as well as its associative and causal links with cancer and inflammatory, metabolic and fibrotic diseases. We also review the development status of small molecule inhibitors targeting HDAC7 and their potential for intervention in different disease contexts.

• Authors: Yizhuo Wang, Rishika Abrol, Jeffrey Y W Mak, Kaustav Das Gupta, Divya Ramnath, Denuja Karunakaran, David P Fairlie, Matthew J Sweet
• Journal: The FEBS journal (FEBS J) Vol. 290 Issue 11 Pg. 2805-2832 (06 2023) ISSN: 1742-4658 [Electronic] England
• PMID: 35303381 (Publication Type: Journal Article, Review, Research Support, Non-U.S. Gov't)
• Copyright: © 2022 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.

Chemical References

• Histone Deacetylases
• Histone Deacetylase Inhibitors

Topics

• Humans
• Histone Deacetylases (metabolism)
• Signal Transduction (genetics)
• Neoplasms
• Inflammation
• Histone Deacetylase Inhibitors (pharmacology, therapeutic use)